CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Project Information

LEGACy

Grant agreement ID: 825832

DOI 10.3030/825832

Project closed

EC signature date 8 December 2018

Start date 1 January 2019

End date 30 June 2023

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 3 993 056,25

EU contribution € 3 577 431,25

Coordinated by

FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA, FUNDACION INCLIVA
Spain

Deliverables

Websites, patent fillings, videos etc. (6)

Quarterly newsletter

Quarterly newsletter Month 4 8 12 16 20 24 28 32 36 40 44 and 48

Website

Set-up of the project web-site including public and private parts

Stakeholder event at completion of the project

Summary report about the stakeholder event, indicating the agenda, the participants and the main ideas treated and the conclusions obtained as well as the actions/compromises that will take place

Patient information brochure
Press release at completion of the project
Twitter/Facebook account

Demonstrators, pilots, prototypes (3)

Online/ face-to face programme course III

Program with the calendar for the online and face-to-face sessions for months 39 to 48 of the project

Online/ face-to face programme course I

Program with the calendar for the online sessions, the face-to-face sessions, and the specific training fellowships planned for the first 18 months of the project

Online/ face-to face programme course II

Program with the calendar for the online and face-to-face sessions for months 21 to 36 of the project

Publications

Other (2)

Comparison of OLGA and OLGIM as predictors of gastric cancer in a Latin American population: the ECHOS Study

Author(s): Gonzalo Latorre, Felipe Silva, Isabella Montero, Miguel Bustamante, Eitan Dukes, Javier Uribe, Oscar Corsi Sotelo, Diego Reyes, Eduardo Fuentes-López, Margarita Pizarro, Patricio Medel, Javiera Torres, Juan Carlos Roa, Sebastián Pizarro, Pablo Achurra, Andrés Donoso, Ignacio Wichmann, Alejandro H Corvalán, Javier Chahuan, Roberto Candia, Carlos Agüero, Robinson Gonzalez, Jose Ignacio Vargas,
Published in: Gut, 2023
Publisher: BMJ Journals
DOI: 10.1136/gutjnl-2023-331059

Terapias cuádruples son superiores a terapia triple estándar en primera línea de erradicación de Helicobacter pylori en Chile

Author(s): Diego Reyes, Javier Ortiz, Eduardo Fuentes-López, Sigall Budnik, Vicente Gándara, Andrea Gallardo, María Francisca Seydewitz, Roberto Candia, José Ignacio Vargas, María Paz Rollan, Javiera Godoy, Antonio Rollan, Rodrigo Mansilla, Alex Arenas, Javier Chahuán, Alberto Espino, Margarita Pizarro y Arnoldo Riquelme
Published in: Gastroenterología y Hepatología, 2021
Publisher: Dialnet

Peer reviewed articles (6)

a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally

Author(s): Tessa Suzanne, van Schooten; Sarah, Derks; Elena, Jiménez-Martí; Fatima, Carneiro; Ceu, Figueiredo; Erika, Ruiz; Maria, Alsina; Cristina, Molero; Marcelo, Garrido; Arnoldo, Riquelme; Carmelo, Caballero; Eva, Lezcano; Juan Manuel, O'Connor; Federico, Esteso; Judith, Farrés; José Manuel, Mas; Florian, Lordick; Jeannette, Vogt; Antonella, Cardone; Charis, Girvalaki; Andrés, Cervantes; Tania, Fle
Published in: BMC CANCER, Issue 3, 2022, ISSN 1471-2407
Publisher: BioMed Central
DOI: 10.1186/s12885-022-09689-9

The Clinical Impact and Cost-Effectiveness of Surveillance of Incidentally-DetectedGastric Intestinal Metaplasia: A Microsimulation Analyses

Author(s): Nikhil R. Thiruvengadam, MD, Shashank Gupta, MD, Seth Buller, BS, Imad Awad, MD, Devika Gandhi, MD, Allison Ibarra, MD, Gonzalo Latorre, MD, Arnoldo Riquelme, MD, Michael Kochman, MD, Gregory Cote, MD, MS, Shailja C. Shah, MD, MPH, Monica Saumoy, MD MS
Published in: Clinical Gastroenterology and Hepatology, 2023, ISSN 1542-7714
Publisher: ElSevier
DOI: 10.1016/j.cgh.2023.05.028

Medicina de precisión en la prevención primaria y secundaria del cáncer gástrico

Author(s): Irina Luzko, Patricio Medel-Jara, Joan Llach, Diego Reyes, Leticia Moreira, Arnoldo Riquelme
Published in: ACTA gastroenterológica Latinoamericana, 2023, ISSN 2469-1119
Publisher: ACTA
DOI: 10.52787/agl.v53i3.349

Mucocutaneous Manifestations in Autoimmune Gastritis: A Prospective Case-Control Study

Author(s): Gonzalez, Agustin MD; Latorre, Gonzalo MD; Paredes, Loreto MD; Montoya, Lorena MD; Maquilon, Sara MD; Shah, Shailja C. MD, MPH; Espino, Alberto MD; Sabatini, Natalia MD; Torres, Javiera MD; Roa, Juan Carlos MD; Riquelme, Arnoldo MD, MMedEd; Kolbach, Marianne MD
Published in: The American Journal of Gastroenterology, 2021, ISSN 0002-9270
Publisher: Blackwell Publishing Inc.
DOI: 10.14309/ajg.0000000000001501

Métodos diagnósticos para la detección de infección por Helicobacter pylori. ¿Cuál y cuándo deben solicitarse?

Author(s): Javier Chahuan, Margarita Pizarro, Arnoldo Riquelme
Published in: ACTA gastroenterológica Latinoamericana, 2022, ISSN 2469-1119
Publisher: ACTA
DOI: 10.52787/agl.v52i1.176

Implementation of the updated Sydney system biopsy protocol improves the diagnostic yield of gastric preneoplastic conditions: Results from a real-world study

Author(s): Gonzalo Latorre, José Ignacio Vargas, Shailja C. Shah, Danisa Ivanovic-Zuvic, Pablo Achurra, Martín Fritzsche, Jai-Sen Leung, Bernardita Ramos, Elisa Jensen, Javier Uribe, Isabella Montero, Vicente Gandara, Camila Robles, Miguel Bustamante, Felipe Silva, Eitan Dukes, Oscar Corsi, Francisca Martínez, Victoria Binder, Roberto Candia, Robinson González, Alberto Espino, Carlos Agüero, Allan Sharp
Published in: Gastroenterología y Hepatología, 2023, ISSN 1578-9519
Publisher: ElSevier
DOI: 10.1016/j.gastrohep.2023.08.005